HR 1829
117th Congress
House
Health
Congressional oversight
Drug therapy
Government employee pay, benefits, personnel management
Government studies and investigations
Health care costs and insurance
Inflation and prices
Medicaid
Medicare
Prescription drugs
Pharmacy Benefit Manager Accountability Study Act of 2021
Introduced: March 11, 2021
Introduced by:
Harshbarger, Diana
Republican
· Tennessee
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 12, 2021
Referred to the Subcommittee on Health.
Mar 11, 2021
Referred to the House Committee on Energy and Commerce.
Mar 11, 2021
Introduced in House
Plain-English summary
Pharmacy Benefit Manager Accountability Study Act of 2021
This bill requires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates and fees, the average prior authorization approval time, and the use of step therapy within the 10 largest pharmacy benefit managers.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2